InvestorsHub Logo

HDGabor

04/04/20 7:20 PM

#262146 RE: alm2 #262048

a-

At least for me: hard to understand your post … what would you like to say … but:

brilliant finding as per your post that Kurcbayashi WAS considered by the POSA as to the Amarin patent application

I try to find the answer that the EXAMINER was consider it or not … POSA - of course - considered it

findings on the Mori trial study

I did not analyze Mori (yet) since the USPTO found LDL-C affect as obvious … just like the Judge.

All together (do not take / see it as an attack): I could not follow your post and no idea what would you like to say …

Best,
G